Integral Diagnostics Ltd. (AU:IDX) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts and uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Capitol Health Limited has received Federal Court approval for its merger with Integral Diagnostics Limited, set to become legally effective on December 11, 2024. Following this, Capitol’s shares will be suspended from trading on the ASX, and new Integral Diagnostics shares will begin trading on December 12, 2024. The merger aims to enhance diagnostic imaging services across Australia.
For further insights into AU:IDX stock, check out TipRanks’ Stock Analysis page.